Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CEG vs MRNA✓SelectedUSD · MRNACEG vs MRNA performance historyLatest closeAs of-4.08%11/19
Stock and ETF performance explorer

CEG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.7%
MRNA return
+715.3%
Excess return
-741.9%
Maximum drawdown
-37.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.1%+1.3%-5.4%-4.1%
7D-10.6%-13.8%+3.2%-10.3%
30D-2.5%-17.7%+15.2%-2.1%
3M-7.9%+14.3%-22.2%-8.4%
6M-3.0%+336.0%-339.0%-7.9%
YTD-28.2%+575.9%-604.2%-31.3%
All-26.7%+715.3%-741.9%-27.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling